Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-label TElmisartan/AMlodipine Single Pill STudy to Assess the Efficacy in Patients With Essential Hypertension"..."

NCT01134393 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01134393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01134393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-label TElmisartan/AMlodipine Single Pill STudy to Assess the Efficacy in Patients With Essential Hypertension"..."
Lead sponsor
Boehringer Ingelheim
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2010
Completion date
Not reported
Enrollment
502 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension